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Abstract
Dorsal–ventral specification in the amphibian embryo is controlled by b-catenin, whose activation in all dorsal cells is
dependent on maternal Wnt11. However, it remains unknown whether other maternally secreted factors contribute to b-
catenin activation in the dorsal ectoderm. Here, we show that maternal Xenopus Norrin (xNorrin) promotes anterior neural
tissue formation in ventralized embryos. Conversely, when xNorrin function is inhibited, early canonical Wnt signaling in the
dorsal ectoderm and the early expression of the zygotic neural inducers Chordin, Noggin, and Xnr3 are severely suppressed,
causing the loss of anterior structures. In addition, xNorrin potently inhibits BMP- and Nodal/Activin-related functions
through direct binding to the ligands. Moreover, a subset of Norrin mutants identified in humans with Norrie disease retain
Wnt activation but show defective inhibition of Nodal/Activin-related signaling in mesoderm induction, suggesting that this
disinhibition causes Norrie disease. Thus, xNorrin is an unusual molecule that acts on two major signaling pathways, Wnt
and TGF-b, in opposite ways and is essential for early neuroectoderm specification.
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Introduction
Dorsal–ventral axis specification is one of the earliest patterning
events in the embryo. In vertebrates, early dorsal ectoderm gives
rise to the neural plate, which in turn develops into the central
nervous system (CNS). Previous studies have found that dorsal axis
formation in amphibians is initiated during cortical rotation after
fertilization. Current evidence strongly suggests that the canonical
Wnt signaling pathway, operating at blastula stages, plays a critical
role in dorsal specification [1]. For example, Wnt signaling was
discovered to induce secondary axes when ectopically activated in
the ventral cells of early embryos. Loss-of-function studies indicate
that the Wnt/b-catenin signaling pathway is also essential for
dorsal specification [2–4]. More recently, Heasman and colleagues
provided strong evidence that vegetally localized maternal Wnt11
cooperates with Wnt5A to activate the canonical Wnt pathway
and is required for dorsal axis formation [5–7]. However, despite
extensive studies on dorsal specification, some observations cannot
be fully explained. For example, although the cortex is rotated
only 30u toward the dorsal side, activated nuclear b-catenin is
observed in all dorsal cells, including dorsal cells near the animal
pole [8]. Previous studies suggested that Wnt pathway components
may be transferred beyond 30u to the dorsal animal region [8,9].
However, it remains unknown whether such movements can fully
account for Wnt activation in dorsal animal cells, and it is also
unclear how these movements precisely regulate the earliest steps
of neuroectoderm formation in the blastula.
In addition to canonical Wnt signaling, the BMP pathway has
also been implicated in neuroectoderm specification and pattern-
ing. During early gastrulation, Noggin, Chordin, and Follistatin
expressed in the Spemann organizer bind to BMPs in the
extracellular space and antagonize their epidermal-promoting
effects [10–12]. These results support a ‘‘default model’’ for neural
induction in which ectoderm cells are predisposed to become
neurons if they receive no BMP signals [13,14]. Genetic screens in
Drosophila and zebrafish have yielded mutants that affect dorsal–
ventral patterning. Interestingly, most of these mutants show
defects in the BMP signaling pathway, indicating that BMP
signaling has a conserved role in dorsal–ventral patterning [1].
On the other hand, dorsal animal cells in the Xenopus blastula
can develop into dorsal and neural tissues cell-autonomously when
cultured in a saline solution [15,16]. De Robertis and colleagues
found that a subset of the dorsal ectoderm cells in the late blastula
expressed Chordin, Noggin, Siamois, and Xnr3 prior to Spemann
PLoS Biology | www.plosbiology.org 1 March 2012 | Volume 10 | Issue 3 | e1001286organizer functioning and referred to these cells as the blastula
Chordin- and Noggin-expressing center (BCNE center) [16]. Early
Chordin and Noggin transcription is activated by maternal b-catenin,
but the precise mechanism underlying this activation remains to be
uncovered [16].
We report here that maternal Xenopus Norrin (xNorrin) is
required for b-catenin activation in dorsal animal cells in the
Xenopus blastula and in early neuroectoderm development. Norrin
is a non-Wnt ligand that was previously shown to activate b-
catenin through LRP5 and Frizzled4 or TSPAN12 during retina
vascular development [17–19]. In humans, mutations in Norrin
cause Norrie disease [20]. We further show that xNorrin can
directly antagonize TGF-b/BMP signaling. Our results not only
identify an endogenous maternal factor required for early
neuroectoderm specification, but may also add TGF-b inhibition
to the increasingly complex regulatory activities of Norrin in
retinal vascular development [17,19].
Results
xNorrin Promotes Dorsal and Anterior Neural Formation
We sought to identify additional secreted molecules that are
involved in neuroectoderm formation. Neuroectoderm is derived
from dorsal animal regions in early Xenopus embryos. Therefore,
we used early neural markers to search for molecules that may be
responsible for early neural specification. In Xenopus, ultraviolet
(UV) irradiation of the vegetal pole in embryos causes severe
dorsal axis development defects [21] (Figure 1A–1F) in otherwise
normal embryos (Figure 1A). We selected a set of candidate genes
Author Summary
A key step during early embryogenesis is the generation of
neural precursors, which later form the central nervous
system. In vertebrates, this process requires proper dorsal–
ventral axis specification, and we know that the canonical
Wnt and BMP signaling pathways help pattern the dorsal
ectoderm. In this study, we examine other factors that are
involved in neuroectoderm development in the frog
species Xenopus laevis. We find that maternal Xenopus
Norrin (xNorrin) is required for canonical Wnt signaling in
the dorsal ectoderm, functions upstream of neural
inducers, and is required for neural formation. We also
find that xNorrin not only activates Wnt signaling, but also
inhibits BMP/Nodal-related signaling. In humans, muta-
tions in Norrin cause Norrie disease. Using Norrin mutants
identified in patients with Norrie disease, we find that
some Norrin mutants fail to inhibit BMP/Nodal-related
signaling (specifically, TGF-b) but retain the ability to
activate the Wnt pathway, suggesting that loss of TGF-b
inhibition may contribute to Norrie disease development.
Figure 1. xNorrin induces anterior CNS formation in ventralized embryos. (A–D) xNorrin mRNA induces anterior neural tissues, while Wnt11
mRNA restores only a partial dorsal axis (without anterior structures) in UV-irradiated embryos. (A) A wild-type embryo (stage 33); (B) an embryo UV-
irradiated (50 mJ) at the vegetal pole; (C) a UV-irradiated embryo injected with Wnt11 mRNA (500 pg) into one cell at the four-cell stage (arrowhead:
partial dorsal axis); (D) a UV-irradiated embryo injected with xNorrin mRNA (500 pg) as in (C) (arrow: head). (E) Summary of (A–D). Fraction of the
population within each group is indicated. (F) Histological analysis of stage 40 embryos. Arrowhead: muscle; arrows: brain and eye. (G–J) Whole-
mount in situ hybridizations to Sox3. (G) A wild-type (WT) embryo (100%, n=65); (H) a UV-treated embryo (4% Sox3 positive, n=70); (I) a UV+Wnt11
(500 pg) rescued embryo (45% Sox3 positive, n=77); (J) a UV+xNorrin (500 pg) rescued embryo (83% Sox3 positive, n=69). All embryos are shown
with the anterior pole to the left. Arrowhead: posterior neural structure; arrow: anterior neural structure. (K) Neural marker expression detected by RT-
PCR. xNorrin induced expression of anterior neural and pan-neural markers (En2, otx2, Xpax6, NCAM, and Sox2) in UV-irradiated embryos. Wnt11
induced only the hindbrain marker Krox20 in UV-irradiated embryos.
doi:10.1371/journal.pbio.1001286.g001
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and tested their ability to reorganize the dorsal axis or anterior
neural tissues by injecting them individually into UV-irradiated
embryos. Among the maternally expressed Wnt genes (Wnt5a,
Wnt8b, and Wnt11) tested, Wnt11 and Wnt8b were able to induce
some dorsal axis structures (Figure 1C and data not shown)
[22,23]. However, none of these molecules triggered the formation
of anterior neural tissues (data not shown).
We also cloned X. laevis xNorrin (GenBank accession number:
EU528658) from unfertilized eggs. This gene encodes a homolog
of human Norrin that can activate b-catenin [18]. The injection of
xNorrin mRNA into UV-ventralized embryos produced a well-
defined head-like structure (Figure 1), including cement gland, eye,
and brain-like tissues (85%, n=97). In contrast, only 5% of UV-
ventralized embryos (n=76) developed any dorsal axial structures
(such as notochord and neural tube), and 49% of Wnt11-injected,
UV-irradiated embryos (n=81) developed dorsal ridges without
notochords and neural tubes (Figure 1C and 1F). Gene expression
analysis showed that xNorrin induced not only pan-neural markers,
such as Sox3, Sox2, and NCAM, but also anterior neural markers,
such as otx2, Xpax6, and En2, in stage 20 embryos (Figure 1J and
1K). In contrast, Wnt11 induced the expression of the rhombo-
mere marker Krox20 (Figure 1K) and only weakly induced the
expression of the pan-neural marker Sox3 (Figure 1I). These results
indicate that xNorrin can promote anterior neural tissue formation
in an otherwise non-neural background. The neural formation
triggered by xNorrin expression in UV-ventralized embryos may
perhaps be attributable to early neuroectoderm induction by the
injected xNorrin.
We reasoned that for maternal xNorrin to act in specifying the
neuroectoderm in a cell-autonomous fashion, it should meet two
criteria. First, it should be expressed in the dorsal ectoderm of the
blastula [16,24]. Second, it should be able to activate canonical
Wnt signaling [16,25]. Indeed, we confirmed that xNorrin mRNA is
expressed in the animal pole of stage 6 oocytes and early cleavage
embryos (Figures 2A, 2C, and S2A). In addition, much more
xNorrin mRNA was detected in dorsal blastomeres than in ventral
blastomeres in 16-cell-stage embryos (Figure 2B).
Norrin proteins are highly conserved among vertebrates (Figure
S1A and S1B). xNorrin, like its mouse ortholog, can activate Wnt-
responsive reporters (data not shown) and induce LRP6
phosphorylation in HEK293T cells (Figure S2C). Next, we
examined whether xNorrin could activate early Wnt target gene
expression in vivo. The injection of xNorrin into UV-irradiated
embryos robustly induced the expression of the known Wnt targets
Chordin, Noggin, Xnr3, and Siamois (Figure 2D). Further, animal caps
injected with xNorrin plus Xenopus Frizzled4 plus human Lrp5
mRNA (NFL) also expressed Xnr3 and Siamois, but not Xbra (Figure
S2B). We noted that xNorrin injection alone did not induce Xnr3 or
Siamois expression in animal caps (Figure S2B), suggesting that
some components of the xNorrin pathway may not be expressed in
the caps (see Discussion). However, the injection of xNorrin into
dorsal animal cells enhanced Chordin expression during the late
blastula and early gastrula stages (Figure 2E). These results suggest
that maternal xNorrin may promote neuroectoderm specification
by activating canonical Wnt signaling.
xNorrin Is Required for Neuroectoderm Specification
To address whether maternal xNorrin is required for neuroec-
toderm specification and hence anterior CNS formation at a later
stage, we used an xNorrin antisense morpholino (MO) oligonucle-
otide (xNor-MO) to inhibit xNorrin translation (Figure 3A). The
inhibition of xNorrin mRNA translation by xNor-MO was both
specific and dose-dependent (Figure 3B). We injected xNor-MO
into the animal region of the two dorsal blastomeres in the four- to
eight-cell embryo stage to suppress endogenous xNorrin translation.
The majority of xNor-MO-injected embryos (61%, n=64)
displayed anterior head truncations, and another 15% of the
embryos lacked morphological eye structures and other anterior
neural structures at tadpole stages (Figure 3D). The injection of a
mismatched MO (misMO), xNor-misMO, that failed to block
xNorrin-Myc translation (data not shown) produced no discernible
phenotype compared to uninjected controls (Figure 3C and 3E).
The specificity of xNor-MO was further tested by the co-injection
of a wild-type xNorrin mRNA lacking the xNor-MO target
sequence. The injection of 25 pg of xNorrin mRNA significantly
rescued the anterior neural development defects in xNor-MO-
injected embryos (Figure 3F) (n=81, 77% rescued). Furthermore,
the injection of xNor-MO into one dorsal animal cell in eight-cell-
stage embryos, while leaving the other side intact, resulted in
severe defects in eye development at later stages (compare
Figure 3G and 3H). Because xNorrin is also expressed zygotically
at later stages, we designed a splicing MO (spMO) to specifically
block its splicing (Figure S3A and S3B). While xNor-MO inhibited
anterior development, xNor-spMO had almost no effect on axis
development (Figure S3C–S3G). We further confirmed that xNor-
Figure 2. Maternal xNorrin activates the canonical Wnt
signaling pathway. (A) RT-PCR analysis of mRNAs from equatorially
bisected oocytes (Egg). xNorrin mRNA is present in the animal half (Ani)
of fully grown oocytes, while Xcat-2 mRNA is present in the vegetal half
(Veg). –RT: no reverse transcription. (B) Both xNorrin mRNA and Wnt11
mRNA are enriched in the dorsal cells of 16-cell embryos. Embryos are
evenly bisected into dorsal and ventral halves. D, dorsal half; V, ventral
half; WE, whole embryo. (C) Spatial and temporal expression patterns of
xNorrin mRNA from fertilized eggs to the late blastula stage (stage 9)
revealed by whole-mount in situ hybridization. (D) xNorrin mRNA
(500 pg) injection into the animal region of UV-ventralized embryos at
one-cell stage reactivates the expression of Siamois, Chordin, Noggin,
and Xnr3 at the late blastula stage. (E) xNorrin injection enhanced
Chordin expression (detected by in situ hybridization) at stage 9 (81%,
n=36) and stage 10 (80%, n=35) compared to wild-type embryos. UV,
UV-irradiated embryos; WT, wild-type embryos; xNorrin, wild-type
embryos injected with xNorrin (500 pg) into the dorsal-animal region
at the four- to eight-cell stage.
doi:10.1371/journal.pbio.1001286.g002
xNorrin Controls Early Neuroectoderm Specification
PLoS Biology | www.plosbiology.org 3 March 2012 | Volume 10 | Issue 3 | e1001286MO preferentially inhibited XBF-1 (an anterior neural marker
[26]) expression in the injected side, while xNor-spMO had a
much weaker effect (Figure S3H). Neither MO had a significant
role in regulating the expression of HoxB9 (a posterior marker [27])
(Figure S3H). These results suggest that maternal xNorrin signaling
is required for anterior CNS formation.
The loss of anterior head development may be an indirect effect
due to a lack of early neuroectoderm specification. Thus, we tried
to address whether b-catenin activation in the ectoderm, which is
indispensable for full dorsal axis formation [3], depends on
xNorrin activity. First, we used a SuperTopFlash Wnt reporter,
which can be activated by injection into the dorsal animal
blastomeres of eight-cell-stage embryos [5] (Figure 3I). The co-
injection of xNor-MO with the reporter plasmid largely blocked
reporter activity compared to co-injection with xNor-misMO
(Figure 3I). In a separate assay, we examined whether maternal
xNorrin was required for the expression of Chordin, Noggin, Xnr3,
and Siamois in dorsal animal cells, which is one of the earliest
indications of b-catenin activation [16]. We found that xNor-MO
reduced the expression of these genes in late blastula embryos
(Figures 3J, S4A, and S4B) but did not interfere with the
expression of gsc or Xnr1 (Figure S4A and S4B) at the early
Figure 3. Maternal xNorrin is required for dorsal ectoderm specification. (A) The xNor-MO target sequence (green line) in xNorrin mRNA. (B)
xNor-MO dose-dependently suppresses xNorrin-Myc (1.5 ng) mRNA translation in Xenopus embryos. xNorrin-Myc was detected using an anti-c-Myc
monoclonal antibody. Uni, no xNorrin-Myc injected. (C–F) xNorrin is required for head formation. (C) A wild-type (WT) stage 35 tadpole. (D) xNor-MO
(20 ng) caused anterior truncation (61%, n=64) when injected into the animal regions of two dorsal cells in four- to eight-cell-stage embryos. (E)
xNor-misMO-injected embryos are generally normal (88%, n=66). (F) The anterior defects caused by NorMO were rescued by xNorrin (25 pg) mRNA
(77%, n=81). (G) Dorsal view of a wild-type tadpole at stage 45. (H) Anterior defects on only one side (arrow) were generated by injecting xNor-MO
(10 ng) into one dorsal cell at the four- to eight-cell stage (63% of injected embryos showed defects in the injected side, n=30). The other side shows
normal morphology. The anterior end is to the left. (I) xNor-MO inhibits Wnt signaling in dorsal animal cells. xNor-MO and SuperTopFlash (STF)
reporter plasmids were co-injected into the dorsal animal cells of eight-cell embryos. F/R luciferase: ratio of firefly luciferase reading to renilla
luciferase reading. (J) Whole-mount in situ hybridization shows that Chordin expression is reduced at stage 9 (53% of injected embryos, n=80) and
stage 10 (61% of injected embryos, n=79) in xNor-MO-injected embryos, compared to xNor-misMO-injected embryos or uninjected embryos. (K–N)
Whole-mount in situ hybridization for Chordin in bisected xNor-MO-injected embryos (stage 9.5) showing that xNor-MO inhibits Chordin expression in
neuroectoderm precursors (arrow) (reduction in 66% of injected embryos, n=104) (L) compared to wild-type embryos (K) and embryos with xNor-
misMO injected into dorsal animal cells at the eight- to 16-cell stage (reduction in 13% of injected embryos, n=78) (M). Note that xNorrin mRNA
(100 pg) rescues Chordin expression in the dorsal ectoderm (80% of co-injected embryos showed expression comparable to wild-type embryos,
n=50) (N). Embryos are oriented such that their dorsal side is on the right. Dotted lines indicate the boundaries between the deep mesoderm and the
superficial ectoderm.
doi:10.1371/journal.pbio.1001286.g003
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xNor-MO embryos can be rescued by the co-expression of
xNorrin (Figure S4B). In late blastula xNor-MO embryos (stage
9.5), the reduction of Chordin expression was mostly restricted to
the ectoderm, while deep dorsal mesoderm cells retained weak
expression (Figure 3L). The ectoderm expression of Chordin in the
later blastula was fully restored by the co-injection of wild-type
xNorrin mRNA lacking the MO target sequence (Figure 3N). In the
blastula ectoderm, Chordin expression is controlled by maternal b-
catenin [16,28]. Thus, the control of early Chordin expression by
xNorrin should partially reflect how xNorrin functions in
neuroectoderm precursors. Together, these results indicate that,
besides vegetally localized Wnt11 activity, maternal xNorrin is
required to activate the canonical Wnt pathway in the dorsal
ectoderm and is essential for the proper expression of early zygotic
neural inducers before gastrulation.
xNorrin-Activated Wnt Signaling Fails to Dorsalize Ventral
Mesoderm
Mouse Norrin is a secreted protein that is tightly associated with
the extracellular matrix [29]. However, we found that xNorrin was
secreted into culture medium when expressed in HEK293 cells
and Xenopus embryo explants (data not shown). The secretion of
xNorrin in the culture cells and its potent activity in early embryos
prompted us to speculate that other mechanisms may be required
to restrict xNorrin activity in early embryos.
We first tested whether xNorrin was active when expressed
ectopically in embryos. Previous studies indicated that the ectopic
activation of the canonical Wnt pathway in the ventral side of
early embryos is sufficient for secondary dorsal axis formation
[30–32]. In addition, the co-expression of NFL was shown to
activate canonical Wnt signaling in tissue culture cells and in
animal cap explants (Figure S2B and S2C). Thus, we examined
whether NFL could mimic canonical Wnt proteins and induce
secondary axes in early embryos. Surprisingly, when injected into
the ventral vegetal cells of early embryos, NFL failed to generate
any complete secondary axes (Figure 4C), while Wnt8 was able to
generate secondary axes, as shown previously [31,32] (Figure 4B).
However, NFL was able to weakly induce partial secondary axes in
which the neural marker Sox3 was detected (Figure 4F). NFL-
injected embryos had neural tubes but not notochords in their
secondary axes (Figure 4I, 4L, and 4L’), while Wnt8-injected
embryos had complete secondary axes containing both neural
tubes and notochords (Figure 4E, H, K, and K’) [31,32].
The failure of NFL-injected embryos to form complete
secondary axes was not due to a lack of activation of Wnt
signaling by NFL, because Chordin, Siamois, and Xnr3 expression
could be detected in the ventral side of the early gastrula (stage 10)
(Figure S4C and S4D). However, Chordin expression was mostly
induced in the superficial layer and not in the deep ventral
mesoderm (Figure 4O). The much lower expression of Chordin in
the deep layer was considered unlikely to be a staining artifact
because strong Chordin signal was readily detected in the dorsal
mesoderm (Figure 4O). Embryos injected ventrally with Wnt8
strongly induced Chordin expression in both germ layers, as
expected (Figure 4N and 4Q). Similarly, the injection of NFL into
ventral animal cells induced Chordin transcription only in the
ventral ectoderm and not in the mesoderm (Figure 4R).
These results suggest that an intrinsic mechanism may exist to
restrict endogenous xNorrin activity to the prospective neuroec-
toderm. Alternatively, injected NFL may alter the cell fate of
endomesoderm, making it incompetent to form dorsal endome-
soderm, even in the presence of canonical Wnt signaling.
xNorrin Inhibits Activin/Nodal-Related Induced
Mesoderm Formation
Because NFL injection failed to activate Wnt target genes in the
endomesoderm (Figure 4O and 4R), we initially proposed that an
xNorrin-specific inhibitor might exist in the endomesoderm.
However, after extensive investigation, we were not able to
identify any molecule that could fulfill the proposed criteria for the
inhibitor, i.e., that it should be expressed specifically in the
endomesoderm and exert its antagonizing activity on xNorrin but
not Wnt8. We thus turned to an alternative possibility, that NFL
may influence the fate of endomesoderm precursor cells, making
the germ layer incapable of conversion into dorsal endomesoderm.
Previously, TGF-b family members, such as Xnr1, -2, -4, -5, and -
6 and derriere were shown to be essential for mesoderm induction
in Xenopus embryos [33]. Zygotic transcription of Xnr genes is
activated by maternal transcription factor VegT and b-catenin.
The Nodal-related molecules form a dorsal–ventral gradient that
induces dose-dependent endomesoderm formation. Higher con-
centration of Nodal-related molecules results in dorsal specifica-
tion [34,35]. In a mesoderm induction assay, we used Activin, in
lieu of Nodal-related molecules, to induce strong axial mesoderm
and convergent extension in animal cap cells (Figure 5A–5C)
[33,36]. When co-expressed in animal cap cells, xNorrin
completely blocked the Activin-induced elongation of animal cap
explants (Figure 5D; compare to Figure 5B and 5C). The
inhibition of mesoderm formation was confirmed by the lack of
expression of the mesoderm markers Xbra, Xwnt8, MyoD, and m-
actin in the co-expressing explants (Figure 5E). In whole embryos,
xNorrin injection into the vegetal pole also blocked Xbra
expression (Figure S5A–S5D). These results suggest that xNorrin
may negatively regulate mesoderm induction in vivo. Next, we
tested whether Xnr1 and xNorrin could be directly associated
extracellularly. We combined and incubated conditioned medium
from Xnr1-transfected HEK293 cells and from xNorrin-transfected
cells and used the medium for immunoprecipitation. Indeed, we
detected an association between Xnr1 and xNorrin (Figure S6B),
suggesting that maternal xNorrin may restrict Nodal-related
activity from extending into the animal pole.
Reciprocal Inhibition between xNorrin and BMP4
Because xNorrin can inhibit Activin/Nodal-related activity, we
hypothesized that it may also antagonize other members of the
TGF-b superfamily. Indeed, we found that xNorrin also strongly
inhibited the activity of a BMP4 reporter (BRE-Luc) (Figure 5F).
As expected, xNorrin also inhibited Smad1 phosphorylation
induced by BMP4 (Figure 5G). One possible mechanism for
inhibition between proteins is through direct binding. We
examined this possibility between BMP4 and xNorrin. To this
end, we injected differently tagged BMP4 and xNorrin mRNAs into
adjacent blastomeres in advanced four-cell-stage embryos to allow
secretion of the respective proteins into the extracellular space. At
late gastrula, protein extract was immunoprecipitated with one tag
antibody and blotted with the other tag antibody. Results showed
that BMP4 was indeed associated with xNorrin extracellularly.
Thus, the inhibition by xNorrin is likely through direct binding to
BMP4 (Figure 5I).
The direct interactions between xNorrin and BMP4 led us to
investigate whether xNorrin activity was regulated by BMP4. We
showed that xNorrin induced neural marker expression in animal
caps (Figure 5H). In an animal cap assay, BMP4 significantly
inhibited the otx2, Xpax6, and NCAM expression induced by
xNorrin (Figure 5H). Thus, reciprocal inhibition between xNorrin
and BMP4 may also be implicated in dorsal–ventral ectoderm
development.
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inhibitors Chordin, Noggin, and Follistatin could induce neural
formation through direct binding [10–12]. Because xNorrin can
also inhibit BMP4, we investigated xNorrin neural induction
activity. Indeed, we found that xNorrin alone can induce the
expression of neural-specific genes in animal cap cells in a dose-
dependent manner (Figures 6A and S5A). The neural promoting
activity of xNorrin in ectodermal cells was confirmed by the Sox3
(a neural marker) expression in xNorrin-injected animal caps
(Figure 6B). Further, xNorrin, like the truncated BMP receptor
DBMPR, can induce ectopic Sox3 and XAG1 (an anterior marker)
expression when injected into one ventral blastomere of 32-cell
embryos (Figure 6C). More importantly, neural induction was
observed when a b-catenin-specific MO was co-injected, indicat-
ing that canonical Wnt pathway activation is not required for
neural formation in this setting (Figure 6A, compare the two b-
catenin-MO-injected lanes). Furthermore, we did not observe
activation of Xnr3 or Siamois in xNorrin-injected animal caps,
confirming the lack of canonical Wnt activation (Figure S2B). We
conclude that xNorrin and BMP4 are reciprocally inhibited and
that xNorrin may promote neural development independent of
Wnt signaling activation.
Loss of TGF-b Inhibition in a Subset of Norrin Mutants
Norrin mutations are responsible for both X-linked familial
exudative vitreoretinopathy (FEVR) and Norrie disease (Online
Mendelian Inheritance of Man MIM#310620) in humans
[37,38]. The finding that Norrin can inhibit BMP/TGF-b activity
prompted us to test whether this regulation is involved in the
disease development. We noticed that some previously identified
Norrin mutants isolated from human patients did not significantly
affect Wnt pathway activation [18,39]. We hypothesized that these
human Norrin mutants might instead be compromised in their
ability to antagonize BMP/TGF-b activities in vivo.
The ectopic expression of xNorrin or mouse Norrin in the vegetal
cells of whole embryos potently inhibited the expression of the
mesoderm-specific marker Xbra, which is dependent on Nodal-
related activity in vivo (Figure 7D compared to 7B and 7C; Figure
S5B–S5D). We thus used this assay to examine the activity of
various xNorrin mutants on Xbra expression. We constructed three
xNorrin point mutants (R40K, L60P, and K57N) based on
mutations identified from human patients. Compared to wild-type
xNorrin, the xNorrin R40K and L60P mutants showed decreased
Xnr3, Siamois, and Chordin expression when co-expressed with Lrp5
and Frizzled4 in animal caps, while xNorrin K57N strongly
Figure 4. xNorrin activity is restricted to the ectoderm. (A–F)
Injection of NFL into ventral vegetal cells at the eight-cell stage induced
partial secondary axes. Wild-type (WT) embryos (stage 28) (A and D).
Injection of Wnt8 mRNA (10 pg) into ventral vegetal cells in eight-cell
embryos induces complete secondary axis formation (stage 28) (69% of
injected embryos showed secondary axes, n=85) (B and E). NFL mRNA
(600 pg total; 200 pg each) co-injection of ventral vegetal cells in eight-
cell embryos induces partial secondary axis formation (stage 28) (45% of
co-injected embryos showed secondary axes, n=105) (C and F). Whole-
mount in situ hybridization for Sox3 in stage 28 embryos (D–F). Note
that NFL induces Sox3 expression in the partial secondary axis
(arrowhead in [F]). The black lines in (A–C) indicate the section planes
in (G–I), respectively. (G–I) Histological sections of embryos at stage 30.
A wild-type embryo (G). Wnt8 mRNA injection induced both secondary
neural tube and notochord (H). NFL co-injection induced secondary
neural tube but not notochord formation (I). Arrowhead: neural tube;
arrow: notochord. (J–L) Immunostaining of notochords with the
monoclonal antibody MZ15. Wild-type embryo with single notochord
(all examined embryos) (J and J’). An embryo injected ventrally with
Wnt8 mRNA (10 pg) showed two notochords (induced secondary
notochord and the primary notochord) (all examined embryos with
secondary axes) (K and K’). An embryo injected ventrally with NFL
(200 pg each) showed only the primary notochord (arrows), with
notochord tissue absent in the partial secondary axis (arrowheads) (all
examined embryos with partial secondary axes) (L and L’). Embryos are
at stage 30. (M–R) NFL and Wnt8 induced Chordin expression in different
domains in the ventral cells. Whole-mount in situ hybridization was
used to evaluate Chordin expression in stage 10 embryos. Chordin
expression in wild-type early gastrula (M and P). Wnt8 mRNA (10 pg)
injection into ventral vegetal cells induced Chordin expression both in
the superficial layer and in the deep layer of the marginal zone (87.5%
of injected embryos showed the expression in both layers, n=24) (N).
Injection of NFL mRNAs (200 pg each) into the same domain induced
Chordin expression mainly in the superficial layer (76% of injected
embryos showed the expression, n=30) (O). Injection of Wnt8 into the
ventral-animal cells of eight-cell embryos induced Chordin expression
both in the ectoderm and in the mesoderm (84% of injected embryos
showed the expression in both layers, n=25) (Q). Injection of NFL
mRNAs (200 pg each) into the same domain of eight-cell embryos
induced Chordin expression only in the ectoderm (72% of injected
embryos showed the expression, n=32) (R). Arrowheads: superficial
layer (O) or ventral ectoderm (R); arrows: deep layers on the ventral side.
All embryos in (M–R) are shown with their dorsal sides to the right.
Dotted lines delineate the superficial layer and deeper layer on the
ventral side.
doi:10.1371/journal.pbio.1001286.g004
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with previous findings using cell culture assays [18,39]. In a whole-
embryo assay, the xNorrin R40K mutant largely inhibited Xbra
expression, while the xNorrin L60P mutant showed only slight
inhibitory activity (Figure 7E and 7G compared to Figure 7B and
7D). In an extreme case, the xNorrin K57N mutant completely
failed to suppress Xbra expression (Figure 7F). A lack of BMP4
binding ability might explain this loss of TGF-b inhibition.
However, only a minor reduction in BMP4 binding was observed
for the xNorrin K57N mutant compared to wild-type xNorrin.
The xNorrin R40K mutant also did not show significantly reduced
binding to BMP4 (Figure S6).
Next,weexaminedwhetheralackofTGF-binhibition by xNorrin
compromised its neural induction function in a loss-of-function
background. Because we could not directly study the K57N mutation
through a knock-in experiment in Xenopus, we tested K57N mutant
function in xNor-MO-injected embryos. In contrast to wild-type
xNorrin, which was able to significantly rescue the anterior defects of
Figure 5. Reciprocal inhibition between xNorrin and TGF-b. (A–E) xNorrin inhibits Activin-B-mRNA-induced mesoderm formation. A wild-type
(WT) embryo at a neurula stage (A). Wild-type animal caps with elongation (5% of the caps showed elongation, n=60) (B). Elongated animal caps
induced by Activin-B mRNA (25 pg) injection (82% of the injected caps showed elongation, n=55) (C). Animal cap elongation was blocked in animal
caps injected with Activin-B (25 pg) and xNorrin (200 pg) mRNAs (10% of the co-injected caps showed elongation, n=58) (D). The Activin-B-mRNA-
induced expression of mesoderm markers (Wnt8, Xbra, m-actin, and MyoD) was inhibited by xNorrin (E). RNAs were injected into the animal pole of
one-cell embryos, and animal caps were cut around stage 8 and cultured in 16MMR until the sibling embryos reached neurula stage. (F and G)
xNorrin inhibits BMP4 signaling. xNorrin mRNA (500 pg), like DBMPR mRNA (200 pg) and Chordin mRNA (100 pg), inhibited BRE-Luc reporter activity
in Xenopus embryos (F). xNorrin mRNA (500 pg) inhibited BMP4-induced Smad1 phosphorylation in animal caps (G). P-Smad1, phosphorylated
Smad1; T-Smad1, total Smad1; WE, whole embryo. (H) BMP4 inhibited xNorrin-induced otx2, Xpax6, and NCAM RNA expression in animal caps of stage
15 embryos. –RT, no reverse transcription; WE, whole embryo; WT, wild-type animal caps. (I) xNorrin interacts with BMP4. BMP4-Flag and xNorrin-Myc
mRNAs or xNorrin-Flag and BMP4-Myc mRNAs were injected into adjacent cells of four-cell embryos. FLAG-tagged proteins were immunoprecipitated
(IP) from later gastrula embryos with a FLAG antibody. The proteins were PAGE separated and immunoblotted (IB) with an anti-c-Myc antibody.
Arrowheads indicate xNorrin-Myc (top) or BMP4-Myc (bottom). L.C., IgG light chain.
doi:10.1371/journal.pbio.1001286.g005
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S7D), the K57N mutant was far less efficient, often producing
phenotypes similar to those of xNor-MO-injected embryos (Figure
S7E). We did not observe normal eye formation in any K57N-
mutant-injected embryos (Figure S7F), suggesting that TGF-b
inhibition is crucial for the full activity of xNorrin.
Together, these results indicate that Wnt activation and TGF-b
inhibition activities are encoded by distinct domains in Norrin
proteins and that the loss of TGF-b inhibition in Norrin mutants
may be a novel mechanism implicated in the development of
Norrie disease in humans (see Discussion).
Discussion
The present work addresses the molecular nature and
mechanism of a maternal signal that specifies the early
neuroectoderm. Our findings reveal an essential coordination of
canonical Wnt signaling activation and extracellular BMP/TGF-b
inhibition by maternal xNorrin and further highlight the
integration of the two major signaling pathways during early
neuroectoderm specification (Figure 8). Our results also point to
the de-repression of BMP/TGF-b as a new molecular mechanism
in Norrie disease.
Figure 6. xNorrin induces neural formation independent of b-
catenin signaling. (A) xNorrin dose-dependently induced neural
marker (Xpax6, otx2, NCAM, and Sox2) expression. The induction is
independent of mesoderm formation (m-actin: muscle actin) and could
occur in the presence of a b-catenin-MO. RNA and MO were injected at
the one-cell stage, and the caps were dissected around stage 8 and
cultured until they reached stage 15. –RT, no reverse transcription; WE,
whole embryo; WT, wild-type. (B) xNorrin induced Sox3 expression in
animal caps (89% of xNorrin injected caps showed the expression,
n=45). xNorrin mRNA (300 pg) was injected into the animal pole of
two-cell embryos. Sox3 expression in stage 15 animal caps was analyzed
with in situ hybridization. WT, wild-type animal caps; xNorrin, xNorrin-
mRNA-injected caps. (C) xNorrin induced the expression of ectopic
neural and anterior markers in whole embryos. xNorrin mRNA (300 pg)
was injected into the ventral animal tier cells of 32-cell embryos.
Expression of Sox3 (by DBMPR: 80%, n=30; by xNorrin: 73%, n=30) and
XAG1 (by DBMPR: 69%, n=35; by xNorrin: 79%, n=34) were induced at
ectopic sites. b-gal, b-gal-mRNA-injected embryos; DBMPR: DBMPR-
mRNA-injected embryos; WT, wild-type uninjected embryos; xNorrin:
xNorrin-mRNA-injected embryos. Arrows: ectopically induced Sox3 or
XAG1. Sox3 expression in wild type is shown in a dorsal view, while
XAG1 expression in wild type is shown in an anterior view. All other
embryos are shown in a ventral view, except the embryo in the b-gal/
Sox3 panel, which is in a lateral view.
doi:10.1371/journal.pbio.1001286.g006
Figure 7. TGF-b inhibition is implicated in Norrie disease. (A)
xNorrin point mutants showed various levels of Wnt activation activity.
Wild-type (WT) or mutant xNorrin and Fizzled4 and Lrp5 (FL) were
injected into animal poles. The expression of Xnr3, Saimois, and Chordin
in animal caps was analyzed by RT-PCR. xNorrin R40K and xNorrin L60P
showed slightly decreased and no Wnt activation, respectively. xNorrin
K57N moderately increased Wnt activation. –RT, no reverse transcrip-
tion; WE, whole embryo. (B–G) xNorrin point mutants showed various
levels of mesoderm inhibition activity. Individual xNorrin point mutant
mRNAs and b-gal mRNA were co-injected into the vegetal halves of
two-cell-stage embryos. The expression of Xbra was analyzed at stage
10.5 by whole-mount in situ hybridization. While wild-type xNorrin
inhibited Xbra expression (83% of the injected embryos showed very
low or no Xbra expression, n=35) (D), xNorrin K57N failed to inhibit
Xbra expression (13% of the injected embryos showed reduced Xbra
expression, n=39) (F). xNorrin R40K (61% of the injected embryos,
n=33) and L60P (41% of the injected embryos, n=32) also showed
decreased Xbra expression (E and G). Uninjected (B) and b-gal-injected
embryos (C). b-gal is stained in red. The embryos are in vegetal views,
but slightly tilted toward marginal zones to show Xbra signal.
doi:10.1371/journal.pbio.1001286.g007
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Neuroectoderm Specification
Canonical Wnt signaling activation in early embryos is essential
for the initial dorsal specification [2,25]. Heasman and colleagues
previously provided strong evidence that Wnt11 and Wnt5A are
endogenous ligands required for b-catenin signaling in all dorsal
cells, including dorsal animal cells [5–7]. These important findings
seem to indicate that any additional Wnt agonists specifically
required for b-catenin activation in dorsal animal cells would be
redundant. However, previous studies suggested that in Xenopus,a n
animal-to-vegetal signal was implicated in promoting neural fate
before gastrulation, and dorsal animal cells from the blastula are
able to develop into neural tissues cell-autonomously in culture
[18,28,40]. Noggin and Chordin were discovered to act as neural
inducers prior to gastrulation. We demonstrated a lack of b-
catenin activation in xNor-MO-injected embryos, which strongly
indicated that Wnt11 activity was not sufficient to compensate for
the loss of xNorrin activity in vivo (Figure 3I). The severe neural
tissue formation defect in xNor-MO embryos is likely due to a
failure in the specification of the early neuroectoderm. The
significant down-regulation of the dorsal marker Chordin supports
this hypothesis (Figure 3J–3N).
If both Wnt11 and xNorrin are involved in dorsal specification,
then why does maternal xNorrin, which is likely retained in
Wnt11-depleted embryos, fail to compensate for the loss of Wnt11
RNA in generating anterior dorsal formation [5]? It is possible that
additional molecules are required for xNorrin function in dorsal
animal cells. For example, cortical rotation may play a role in the
activation of xNorrin signaling. In fact, we found that the dorsal
enrichment of xNorrin was lost in UV-irradiated embryos
(Figure 2B and 2C and data not shown). One possibility is that
a vegetal signal, such as Wnt11, may be required to fully activate
xNorrin signaling in the dorsal ectoderm during cortical rotation.
Candidate targets of this vegetal signal may include Xenopus
Frizzled4 and Xenopus LRP5, two known receptors for xNorrin
[18]. Similarly, the absence of Xnr3 and Siamois expression in
xNorrin-injected animal caps can be attributed to the lack of
functional xNorrin receptors, which are required for xNorrin
signaling (Figure S2B).
Reciprocal Inhibition between xNorrin and TGF-b
In early embryos, balanced signaling activities from opposite
domains are critical for patterning the dorsal–ventral, anterior–
posterior, and animal–vegetal axes. For example, in the Xenopus
gastrula, ventral BMP molecules antagonize Chordin and Noggin
from dorsal cells through direct binding in the extracellular space
[1]. Similarly, mesoderm-promoting Nodal activity in the vegetal
pole is negatively regulated by maternal TGF-b signaling
inhibitors, such as Coco and Ectodermin, from the animal half
[41,42]. In addition, the competence of blastomeres to form neural
and retinal progeny is repressed by endomesoderm-promoting
factors in the vegetal pole [43].
Previously, Coco expressed at the animal pole was proposed as a
competence factor to block Nodal signaling and ensure the correct
patterning of the ectoderm [41]. Our results indicate that xNorrin
also directly inhibits BMP/TGF-b signaling, likely through direct
extracellular binding without the activation of Wnt signaling
(Figures 5 and 6). It is possible that this BMP antagonizing activity
is required to predispose the dorsal ectoderm toward neural fates
before zygotic BMP inhibitors are expressed. Both maternal Coco
and xNorrin are expressed in overlapping domains in the animal
pole of Xenopus oocytes [41]. It would be interesting to investigate
how distinct TGF-b antagonists are coordinated to modulate
multiple TGF-b signaling pathways in vivo. Although both Coco
and xNorrin are TGF-b antagonists, there is a clear difference in
that Coco also functions as a Wnt inhibitor by some unknown
mechanism, while xNorrin is a Wnt agonist.
We also showed that the ectopic expression of xNorrin in the
vegetal-marginal regions inhibited mesoderm formation and
blocked gastrulation (Figure 7D and data not shown), underscor-
ing the importance of restricting xNorrin activity to the dorsal
animal pole. This result seems to suggest that the xNorrin-
mediated inhibition of mesoderm formation may account for the
unexpected failure of NFL to induce complete secondary axes on
the ventral side (Figure 4). However, we observed that the
combination of the xNorrin K57N mutant, Frizzled4,a n dLrp5 also
failed to induce secondary axes (data not shown), suggesting that
an alternative mechanism must prevent NFL from inducing
secondary axes (Figure 4) [18]. A putative Norrin-specific
Figure 8. A model of dorsal specification in Xenopus. During oogenesis, maternal xNorrin and Wnt11 are localized to the animal and vegetal
poles, respectively. After fertilization, both mRNAs are enriched at the dorsal side, leading to two localized activity domains: BCNE center and
Nieuwkoop center. xNorrin in the dorsal animal cells helps to specify neuroectoderm fate by activating a Wnt/b-catenin signaling domain, the BCNE
center, and also participates in antagonizing the Nodal-related signal from the vegetal half and the BMP signal from the ventral side. Wnt11 in the
dorsal vegetal domain is required for b-catenin activation in all dorsal regions, including in the BCNE center. Yellow: xNorrin and BCNE center. Purple:
Wnt11. Red dots indicate stabilized b-catenin. Green: Nieuwkoop center.
doi:10.1371/journal.pbio.1001286.g008
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excluded.
The BMP/TGF-b inhibition function of xNorrin may be
attributed to a predicted cysteine-knot domain in the carboxyl
terminal (Figure S1) [44]. A previous bioinformatics study
classified the putative Norrin cysteine-knot domain as a mucin
protein, along with secretory mucin and von Willebrand factor
[45]. Other members of this subgroup may be tested for their
potential ability to negatively regulate TGF-b family members.
Conversely, BMP4 was shown to repress Norrin-induced neural
formation (Figure 5H). In addition to xNorrin RNA localization in
the dorsal animal region, ventrally expressed BMP4 and vegetally
expressed mesoderm inducers, such as Nodal, may further restrict
xNorrin activity to the prospective neuroectoderm. Thus,
reciprocal inhibition between BMP/TGF-b and xNorrin are
equally important for appropriate embryonic patterning.
A Link between TGF-b Signaling and Norrie Disease
Norrin has been identified as an activator of the canonical Wnt
signaling pathway through two separate receptor complexes,
Frizzled4/Lrp5 and Frizzled4/TSPAN12 [17–19]. Given the
direct link between Norrin mutations and Norrie disease, and the
roles of TGF-b signaling in multiple human diseases, it is
important to recognize that Norrin also functions as a potent
inhibitor of TGF-b family members. Two lines of evidence
indicate that canonical Wnt signaling and TGF-b inhibition are
induced separately by Norrins. First, xNorrin can induce neural
formation in the absence of Wnt target activation (Figure 6A).
Second, selected xNorrin point mutants (e.g., K57N) potently
suppress endogenous TGF-b target gene expression but maintain
robust Wnt activation capability (Figure 7).
One of the major defects caused by Norrie disease is abnormal
vascular development in the retina and inner ear [18]. The
development of the elaborate vascular structure in the retina is
strongly influenced by VEGF, which in turn can be positively
regulated by TGF-b/ALK5 signaling [46]. Although Norrin
mutations cause retinal hypovascularization, a previous study
showed that the numbers of blood vessels in the ganglion cell layer
and the nerve fiber layer are actually increased in the Norrin
knock-out mice [47], suggesting a pro-angiogenesis activity that
may be enhanced in these cell layers. Because Norrin hemizygous
mutant mice also have severe defects in ear and brain development
[18,48], further investigation of local TGF-b regulation in these
organs is also warranted.
Finally, the finding that two independent activities are encoded
in the small Norrin protein (mature human Norrin has only 109
amino acid residues) raises the question of how Wnt pathway
activation and TGF-b signal tuning are coordinated by Norrin in
vivo. Solving the three-dimensional structures of the wild-type
Norrin protein and selected point mutants may help answer this
question and may even help elucidate the molecular mechanisms
of Wnt agonist signaling through its receptors.
Materials and Methods
Plasmid and mRNA
The initial xNorrin cDNA clone was first amplified from a X.
laevis cDNA library using Pyrobest DNA polymerase (TaKaRa)
and PCR primers partially based on a predicted X. tropicalis Norrin
gene sequence. (http://genome.jgi-psf.org/cgi-bin/dispGeneMo-
del?db=Xentr4&id=158316): xNorrin Up: 59-AGACGAATT-
CACCTGAGAGGAAGACTGGG-39, xNorrin Down: 59-AG-
ACCTCGAGAGCAACGCAAGCGAATGG-39. The cDNA for
the coding region was amplified using xNorrin Up: 59-AATCG-
GATCCATGGGAAATCGTGTCCTTC-39 and xNorrin Down:
59-ATATCTCGAGCTATGAATTGCACTCTTC-39. The xNor-
rin cDNA was then cloned between the BamHI and XhoI sites of
pCS2
+. The xNorrin59-Myc plasmid was generated by inserting
xNorrin cDNA, including the 59 UTR, between the BamHI and
ClaI sites of pCS2
+MT, thereby introducing a C-terminal Myc-
tag. The pCS2
+ xNorrin-FLAG plasmid was generated by inserting
xNorrin cDNA between the BamHI and XbaI sites of pCS2
+-
FLAG-C4. The xNorrin single point mutants (R40K, K57N, and
L60P), which mimic human Norrie disease mutants, were
generated by site-direct mutagenesis (Fast Mutagenesis System,
TransGen) [18].
The mRNA for Xenopus injections was prepared using the
RiboMax Large Scale RNA Production System (Ambion)
according to the manufacturer’s instructions. The pCS2
+-xNorrin,
pCS2
+-xNorrin (R40K, K57N, or L60P), xNorrin-Myc, pCS2
+-
xFrizzled4 [49], pCS2
+-hLrp5 [50], and Wnt8 [31] plasmids were all
linearized with NotI; BMP4 was linearized with EcoRI; and Wnt11
[51] was linearized with BamHI. All plasmids were transcribed
with SP6 RNA polymerase. RNA microinjections were carried out
as described [52].
Embryo Manipulation and Injection
All animal studies in this report were approved by the
Institutional Review Board of the Institute of Genetics and
Developmental Biology, Chinese Academy of Sciences. X. laevis
eggs were isolated in 16MBS plus high salt solution and fertilized
using sperm suspensions in 16MMR. Embryos were cultured in
0.16 MMR. Embryo dissection was performed as previously
described [52]. Briefly, mid-blastula embryos were transferred into
16Steinberg’s solution, the vitelline membrane was removed, and
363m m
2 animal caps were cut. Explants were cultured in 16
Steinberg’s solution until they reached the indicated stages [53].
For MO oligonucleotides and mRNA injections, embryos were
transferred into 16 MMR containing 2% Ficoll (Amersham
Biosciences). Pigment intensity was used to differentiate the dorsal
and ventral sides. After injections, embryos were washed
thoroughly and returned to 0.16MMR during the blastula stage.
For UV treatment, embryos were irradiated by placing them in
a quartz colorimetric cup oriented with the animal pole upwards
and UV-irradiated at 50 mJ using the Stratagene Crosslinker 1800.
Immediately after irradiation, the embryos were transferred into
16MMR containing 2% Ficoll. For rescue experiments, four- to
eight-cell-stage embryos were injected with 500 pg of xNorrin
mRNA or 500 pg of Wnt11 mRNA [23].
Antisense Morpholinos
xNorrin antisense MOs were purchased from Genetools. The
MO sequences used were: xNor-MO: CTCAATCCCAGTC-
TTCCTTTCAGGT, xNor-misMO: CTGAATCCGAGTGTT-
CGTTTCACGT, and xNor-spMO: TTAAAGTGGACTGTA-
CCTTGGCAGT. MOs were dissolved in sterile, filtered water at
a concentration of 5 ng/nl and injected at the doses described in
the text.
Reverse Transcription PCR
Total RNA was prepared using the Proteinase K method and
treated with 10 mg of yeast tRNA and RNase-free DNase
(Promega) before cDNA synthesis [52]. cDNA was synthesized
by reverse transcription, and the reactions were performed in a
volume of 20 ml using 200 ng of random primer (Promega), 56
first-strand buffer, 0.01 M DTT, 40 U RNase inhibitor (TaKaRa),
1 mM each dNTP, and 200 U M-MLV RT (Invitrogen) at 37uC
for 50 min. Reactions were then heat-inactivated at 70uC for
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as a template for PCR. PCR was carried out in a volume of 25 ml
containing 100 mM dNTPs, 0.2 mM each primer, and 1 U of
rTaq DNA polymerase (TaKaRa). The PCR parameters and
DNA primers are described in Table S1. PCR cycles were
determined such that no amplification saturation was reached in
semi-quantitative assays.
Luciferase Assays
SuperTopFlash DNA (20 pg), containing eight copies of the
TCF-binding site upstream of a minimal TK promoter and the
luciferase open reading frame, and pRL-TK DNA (10 pg) (Renilla
luciferase was used as an internal control) [5] were co-injected into
two dorsal animal cells at the eight-cell stage of wild-type, xNor-
MO (20 ng)–injected, or xNor-misMO (20 ng)–injected embryos
Three replicate samples for each of the three embryo types were
frozen at the late blastula stage, and luciferase assays were carried
out using a Promega Luciferase Assay system.
Western Blot
To test for xNor-MO activity, one-cell-stage embryos were
injected with 5 ng, 10 ng, or 20 ng of xNor-MO at the marginal
zone and then injected four times with a total of 1.5 ng of xNorrin-
Myc mRNA into the marginal zone at the four-cell stage. A total of
five blastula embryos were homogenized in 100 ml of ice-cold lysis
buffer [54]. Protein lysates were spun for 15 min at high speed at
4uC. Protein detection by Western blot was performed using anti-
c-Myc (9E10) primary (Santa Cruz Biotechnology) and HRP-
conjugated secondary (Pierce) antibodies with Pierce Western blot
detection reagents.
For co-immunoprecipitation assays, 500 pg of xNorrin-Myc and
500 pg of BMP4 mRNA were injected into different cells of four-
cell-stage embryos. The injected embryos were frozen at stage 10
in batches of five and lysed with 500 ml of ice-cold lysis buffer. The
cleared lysate was mixed with anti-FLAG-M2 agarose beads and
incubated overnight at 4uC. The beads were pelleted, washed four
times with lysis buffer, mixed with SDS-PAGE sample buffer, and
processed in a standard electrophoresis and Western blot protocol.
Whole-Mount In Situ Hybridization
Whole-mount in situ hybridization was performed according to
a standard protocol as described previously [55], with minor
modifications for dissected embryos. For dissected embryos, whole
pigmented embryos were fixed for 1 h in MEMFA, bisected along
the dorsal–ventral axis with a scalpel blade, fixed for two
additional hours in MEMFA, and washed and stored in 100%
methanol. The embryos were hybridized at 65uC overnight. BM
Purple was used as a substrate (Roche). Pigment was then
bleached. The RNA probes were labeled with digoxigenin-UTP
(Roche) with the appropriate RNA polymerase using linearized
plasmids.
Histological Analysis
For histological analysis, embryos were fixed overnight in
Bouin’s solution and then dehydrated and embedded in paraffin.
Sections of 10-mm thickness were prepared and stained with
hematoxylin and eosin as previously described [56].
Supporting Information
Figure S1 Norrins are highly conserved in vertebrates.
(A) An alignment of Norrin protein sequences from selected
vertebrate species. Prefixes used for Norrins from different species:
human (h), mouse (m), chicken (c), X. laevis (xl), X. tropicalis (xt), and
zebrafish (z). Conserved cysteine residues are highlighted in red.
(B) Percentages of identical amino acid residues between Norrin
proteins from different species.
(TIF)
Figure S2 Maternal xNorrin activates the canonical Wnt
pathway. (A) xNorrin expression during early Xenopus develop-
ment detected by reverse transcription PCR (RT-PCR). ODC
(ornithine decarboxylase) served as a loading control. RT–: no
reverse transcription. Embryos were staged according to Nieuw-
koop and Faber [53]. (B) Expression of Siamois and Xnr3 (Wnt
target genes) and Xbra (mesoderm marker) in isolated animal caps
from embryos co-injected with NFL (200 pg each), xNorrin
(200 pg), or Wnt8 (10 pg) mRNAs. Nor, Norrin; WE, whole
wild-type embryo; WT, wild type. ODC served as a loading
control. (C) Norrin can lead to phosphorylation of its receptor,
LRP6. LRP6 phosphorylation at three specific threonine (T) and
serine (S) sites (T1479, S1490, and T1493) was analyzed in
HEK293 cells transfected with Lrp6/Axin/mFz4, with or without
mouse Norrin or xNorrin, using site-specific antibodies. Total LRP
was detected using a general LRP antibody.
(TIF)
Figure S3 Maternal xNorrin is required for anterior
neural formation. (A) The genomic sequence of the first exon
and the first intron boundary of xNorrin. The first two
presumptive nucleotides ‘‘gt’’ of the intron are labeled in red.
The splicing site sequence targeted by xNor-spMO is indicated by
a green line. See Materials and Methods for sequence information
for all MOs. (B) RT-PCR to detect xNorrin mRNA expression in
stage 15 embryos. xNor-spMO (20 ng) inhibited zygotic xNorrin
transcription, while xNor-MO (20 ng) or xNor-misMO (20 ng) (a
four-nucleotide mismatched MO compared to xNor-MO) did not.
(C–F) Representative MO-injected tadpole at stage 34. xNo-
spMO (20 ng) did not cause severe anterior defects, unlike xNor-
MO. (G) Summary of (C–F). Uninjected: n=30; MO: n=24;
misMO: n=30; spMO: n=40. (H) xNor-MO injection inhibited
anterior neural formation. Whole-mount in situ hybridization was
performed for XBF-1 mRNA (anterior neural marker) and HoxB9
mRNA (posterior neural marker) in stage 15 embryos. Dorsal
animal cell injection of xNor-MO (10 ng) at the four- to eight-cell
stage greatly reduced the expression of the anterior neural marker
XBF-1 (63%, n=32), while injection of xNor-misMO (10 ng) or
xNor-spMO (10 ng) (27%, n=29) was far less effective to reduce
the expression. Neither xNor-MO (n=25) nor xNor-spMO
(n=25) injection affected HoxB9 expression. MOs were co-injected
with b-gal mRNA (100 pg). b-gal staining is shown in red. XBF-1
staining embryos are shown in anterior view, and HoxB9 staining
embryos are shown in dorsal view, with the anterior pole at the
top. misMO, xNor-misMO; MO, xNor-MO; spMO, xNor-spMO.
(TIF)
Figure S4 xNorrin is essential for early dorsal-specific
gene expression. (A) The injection of xNor-MO reduced Xnr3
(stage 9: 70% reduced, n=17; stage 10: 70% reduced, n=20) but
not gsc (14% reduced, n=22) expression, as assayed by whole-
mount in situ hybridization. (B) RT-PCR analysis showed that
xNor-MO injected into dorsal animal cells reduced the expression
of early dorsal-specific genes in stage 9 embryos. This reduction
could be rescued by the injection of xNorrin mRNA (50 pg) lacking
the xNor-MO target sequence. Note that xNor-MO did not
change Xnr1 expression. ODC served as a loading control. (C) The
overexpression of NFL in ventral vegetal blastomeres induced Wnt
target gene expression. Upon injection into the ventral blastomeres
of early eight-cell embryos, both NFL and Wnt8 induced Xnr3
(NFL: 56%, n=25; Wnt8: 83%, n=46) and Chordin (NFL: 72%,
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induced the Spemann organizer marker gsc (NFL: 7%, n=28;
Wnt8: 84%, n=50). All embryos are in vegetal views. Arrowheads
indicate the injection sites. (D) RT-PCR results (not quantitative)
showed that NFL injection into ventral-vegetal cells ectopically
activated Wnt target genes (Chordin, Siamois, and Xnr3) at the
ventral side of the embryos. ODC served as a loading control.
(TIF)
Figure S5 xNorrin induces neural formation and inhib-
its mesoderm formation. (A) RT-PCR analysis of neural gene
expression in stage 15 animal caps from embryos injected with
Wnt8 (20 pg), Wnt11 (200 pg), xNorrin (xNor) (200 pg), and NFL
(200 pg each). The expression of otx2, Sox2, and NCAM (all neural
markers) was analyzed. ODC served as a loading control. (B–D)
Xbra expression detected in whole-mount in situ hybridization. A
wild-type embryo at stage 10.5 (B); reduced Xbra expression in
stage 10.5 embryos injected with xNorrin RNA (200 pg) at the
vegetal pole at the two-cell stage (82% reduced, n=34) (C);
reduced Xbra expression in stage 10.5 embryos injected with
mouse Norrin RNA (200 pg) at the vegetal pole at the two-cell stage
(66% reduced, n=36) (D).
(TIF)
Figure S6 xNorrin interacts with TGF-b family mem-
bers. (A) xNorrin binds to BMP4. Epitope-tagged wild-type
xNorrin or xNorrin point mutants (R40K or K57N) and BMP4
were separately expressed in HEK293 cells. The conditioned
medium from cells expressing individual xNorrin and BMP4 were
mixed and incubated. The FLAG-tagged protein complexes were
immunoprecipitated using an anti-FLAG antibody and separated
in SDS-PAGE and blotted. An anti-c-Myc antibody was used to
detect Myc-tagged BMP4. The expression of FLAG-tagged
proteins was detected using an anti-FLAG antibody. xNorrin
was shown to bind to BMP4. The R40K mutant retained this
binding activity, while the K57N mutant showed slightly reduced
BMP4 binding. Conditioned medium of the parent FLAG-
plasmid-transfected cells was used as a control (ctrl). Arrowhead,
BMP4-Myc; arrow, immunoglobulin light chains (LC). a-FLAG,
anti-FLAG tag monoclonal antibody; a-Myc, anti-c-Myc-tag
monoclonal antibody. (B) xNorrin binds to Xnr1 but not DKK-
1. The assay performed was similar to that described in (A).
Conditioned medium (ctrl) was the same as in (A). Arrowheads
indicate FLAG-tagged protein. Arrows point to immunoglobulin
heavy chain (HC, top) and light chain (LC, bottom).
(TIF)
Figure S7 The xNorrin K57N mutant failed to efficiently
rescue anterior defects in xNorrin morphants. (A–E) An
uninjected embryo (A). A xNor-MO (20 ng)–injected embryo (B).
Note the lack of eye pigment. A xNor-misMO (20 ng)–injected
embryo (C). A xNor-MO and wild-type Norrin RNA (50 pg) co-
injected embryo (D). A xNor-MO and xNorrin K57N RNA (50 pg)
co-injected embryo (E). (F) Summary of anterior defect frequency
in (A–E). Uninjected: n=40; MO: n=24; xNor rescue: n=20;
K57N rescue: n=19; misMO: n=15. RNAs and MO were
injected into the dorsal animal region at the four-cell stage. All
embryos shown are around stage 36.
(TIF)
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